GSK’s Low-Carbon Ventolin Revolutionizes Inhalers

GSK’s Low-Carbon Ventolin Revolutionizes Inhalers, Significantly Reducing Healthcare’s Carbon Footprint

GlaxoSmithKline (GSK) has unveiled a groundbreaking propellant technology for inhaler devices, aimed at significantly reducing their contribution to greenhouse gas…